000			02321 a2200601 4500
005			20250516061535.0
264		0	_c20120504
008			201205s 0 0 eng d
022			_a1556-1380
024	7		_a10.1097/JTO.0b013e31822eebf9 _2doi
040			_aNLM _beng _cNLM
100	1		_aPietanza, M Catherine
245	0	0	_aXL647--a multitargeted tyrosine kinase inhibitor: results of a phase II study in subjects with non-small cell lung cancer who have progressed after responding to treatment with either gefitinib or erlotinib. _h[electronic resource]
260			_bJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer _cJan 2012
300			_a219-26 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAzabicyclo Compounds _xadverse effects
650	0	4	_aCarcinoma, Non-Small-Cell Lung _xdrug therapy
650	0	4	_aDisease Progression
650	0	4	_aDisease-Free Survival
650	0	4	_aDrug Resistance, Neoplasm _xgenetics
650	0	4	_aErbB Receptors _xgenetics
650	0	4	_aErlotinib Hydrochloride
650	0	4	_aFemale
650	0	4	_aGefitinib
650	0	4	_aHumans
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMutation
650	0	4	_aProtein Kinase Inhibitors _xtherapeutic use
650	0	4	_aProtein-Tyrosine Kinases _xantagonists & inhibitors
650	0	4	_aQuinazolines _xadverse effects
650	0	4	_aTreatment Outcome
700	1		_aLynch, Thomas James
700	1		_aLara, Primo N
700	1		_aCho, John
700	1		_aYanagihara, Ronald H
700	1		_aVrindavanam, Nandagopal
700	1		_aChowhan, Naveed Mahfooz
700	1		_aGadgeel, Shirish M
700	1		_aPennell, Nathan A
700	1		_aFunke, Roel
700	1		_aMitchell, Ben
700	1		_aWakelee, Heather A
700	1		_aMiller, Vincent A
773	0		_tJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer _gvol. 7 _gno. 1 _gp. 219-26
856	4	0	_uhttps://doi.org/10.1097/JTO.0b013e31822eebf9 _zAvailable from publisher's website
999			_c21243760 _d21243760